|
1. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005 Jun;51(6):931-8.
2. Grundy SM. Point: the metabolic syndrome still lives. Clin Chem. 2005 Aug;51(8):1352-4.
3. Reaven G. Counterpoint: just being alive is not good enough. Clin Chem. 2005 Aug;51(8):1354-7.
4. Meisinger C, Koletzko B, Heinrich J. Metabolic syndrome: older than usually assumed, but still too young to die. Clin Chem. 2006 May;52(5):897-8.
5. Reaven GM.Banting lecture 1988. Role of insulin resistance in human disease.Diabetes. 1988 Dec;37(12):1595-607.; Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005 Dec;47(4):201-10.
6. American Heart Association; National Heart, Lung, and Blood Institute, Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2005 Nov-Dec;13(6):322-7.
7. Reaven GM.Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121-31.
8. Zimmet P.Diabesity - the biggest epidemic in human history. MedGenMed. 2007 Aug 20;9(3):39.
9. Castro JP, El-Atat FA, McFarlane SI, Aneja A, Sowers JR.Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep. 2003 Oct;5(5):393-401.
10. Sauerwein HP.The dysmetabolic syndrome: epidemiology and etiology. Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:1-9.
11. Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004 Mar 18;350(12):1220-34.
12. Samaras K. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection. J Antimicrob Chemother. 2007 Dec 10.
13. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004 Jun 17;350(25):2549-57.
14. Delarue J, Magnan C.Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007 Mar;10(2):142-8.
15. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: The missing link between insulin resistance and obesity. Diabetes Metab. 2007 Dec 17.
16. Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia. 2007 Dec;50(12):2562-71.
17. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319-36.
18. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care. 1998 Apr;21(4):649-54.
19. Clark CM Jr, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care. 1997 May;20(5):867-71.
20. Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J.Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998 Jan;21(1):62-8.
21. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993 Feb;76(2):275-8.
22. Balkau B, Eschwège E.Insulin resistance: an independent risk factor for cardiovascular disease? Diabetes Obes Metab. 1999 May;1 Suppl 1:S23-31.
23. Sarafidis PA, Bakris GL.Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach. J Cardiometab Syndr. 2006 Fall;1(5):334-42.
24. Schröder AK, Tauchert S, Ortmann O, Diedrich K, Weiss JM. Insulin resistance in patients with polycystic ovary syndrome. Ann Med. 2004;36(6):426-39.
25. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004 Feb;89(2):453-62.
26. Smith SC Jr.Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med. 2007 Mar;120(3 Suppl 1):S3-S11.
27. Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007 May;132(6):2191-207.
|